Samsara BioCapital, L.P. - Significant Ownership

Signature - Title
Samsara BioCapital, L.P. - By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Samsara BioCapital, L.P..

Significant Ownership of Samsara BioCapital, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 61.2% 11.4M Samsara BioCapital, L.P. Mar 18, 2025
MLYS MINERALYS THERAPEUTICS, INC. Common Stock 9.1% $76.6M 5.74M Srinivas Akkaraju Mar 13, 2025
PVLA Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share 6.1% $19.7M 679K Samsara BioCapital, L.P. Dec 13, 2024
IOBT IO Biotech, Inc. Common Stock, $0.001 par value per share 3.8% $2.42M 2.63M Samsara BioCapital, L.P. Dec 31, 2024
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 2.6% $56.6K 707K Samsara BioCapital, L.P. Nov 18, 2024

Schedules 13D/G Reported by Samsara BioCapital, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.